SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4kt1'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSG_B_MK1B902_2 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.88A	1hsgB-4kt1A: undetectable	1hsgB-4kt1A: 10.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	3 / 3	ASP A 147 PHE A 149 VAL A 144	None	0.54A	1kijB-4kt1A: undetectable	1kijB-4kt1A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OHR_A_1UNA201_1 (ASPARTYLPROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 11	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.91A	1ohrA-4kt1A: undetectable	1ohrA-4kt1A: 10.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P91_B_SAMB2401_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE A)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 62 GLY A 47 GLY A 45 LEU A 101 PRO A 73	None NAG A 601 (-4.2A) None None None	0.97A	1p91B-4kt1A: undetectable	1p91B-4kt1A: 19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TBF_A_VIAA501_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 9	LEU A 232 LEU A 216 VAL A 168 LEU A 182 PHE A 221	None	1.14A	1tbfA-4kt1A: undetectable	1tbfA-4kt1A: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TW4_A_CHDA131_0 (FATTY ACID-BINDING PROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 11	LEU A 367 ASN A 399 ILE A 377 LEU A 358 PHE A 385	None	1.34A	1tw4A-4kt1A: undetectable	1tw4A-4kt1A: 13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZLQ_A_ACTA1502_0 (NICKEL-BINDING PERIPLASMIC PROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 5	PRO A 32 GLY A 47 ASN A 67 GLY A 45	None NAG A 601 (-4.2A) None None	0.97A	1zlqA-4kt1A: undetectable	1zlqA-4kt1A: 25.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOI_C_FRDC305_1 (POL POLYPROTEIN PEPTIDE INHIBITOR)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 5	GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	2aoiA-4kt1A: undetectable	2aoiA-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOI_C_FRDC305_2 (POL POLYPROTEIN PEPTIDE INHIBITOR)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 5	LEU A 72 PRO A 52 VAL A 51 ILE A 69	None	0.94A	2aoiB-4kt1A: undetectable	2aoiB-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AVV_E_MK1E902_3 (POL POLYPROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.89A	2avvE-4kt1A: undetectable	2avvE-4kt1A: 10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CDQ_A_SAMA1500_0 (ASPARTOKINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 8	ILE A 64 SER A 44 ASP A 42 LEU A 62	None	0.99A	2cdqA-4kt1A: undetectable	2cdqA-4kt1A: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CEO_B_T44B1395_1 (THYROXINE-BINDING GLOBULIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 10	GLN A 342 LEU A 315 LEU A 338 SER A 351 LEU A 350	None	1.33A	2ceoB-4kt1A: undetectable	2ceoB-4kt1A: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIP_C_MTXC613_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	VAL A 120 LEU A 184 LEU A 173 PHE A 149 LEU A 155	None	1.24A	2oipC-4kt1A: undetectable	2oipC-4kt1A: 22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PYM_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.80A	2pymA-4kt1A: undetectable	2pymA-4kt1A: 12.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PYM_A_1UNA1001_2 (PROTEASE RETROPEPSIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.83A	2pymB-4kt1A: undetectable	2pymB-4kt1A: 12.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PYN_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.82A	2pynA-4kt1A: undetectable	2pynA-4kt1A: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q83_B_ADNB2_1 (YTAA PROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 6	ILE A 69 PRO A 121 LEU A 101 ILE A 96	None	0.98A	2q83B-4kt1A: undetectable	2q83B-4kt1A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QJU_A_DSMA801_1 (TRANSPORTER)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 11	LEU A 134 LEU A 110 ARG A 135 ALA A 89 ASP A 137	None	1.19A	2qjuA-4kt1A: undetectable	2qjuA-4kt1A: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCT_A_ASDA1223_1 (GLUTATHIONE S-TRANSFERASE A2)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 8	ILE A 260 LEU A 232 LEU A 230 PHE A 268	None	0.89A	2vctA-4kt1A: undetectable	2vctA-4kt1A: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Z54_A_AB1A200_2 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.91A	2z54B-4kt1A: undetectable	2z54B-4kt1A: 10.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CYX_A_ROCA201_1 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.80A	3cyxA-4kt1A: undetectable	3cyxA-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D1X_A_ROCA201_2 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.91A	3d1xB-4kt1A: undetectable	3d1xB-4kt1A: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D1Y_A_ROCA201_1 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	3d1yA-4kt1A: undetectable	3d1yA-4kt1A: 13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM4_A_DR7A100_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 11	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	3em4A-4kt1A: undetectable	3em4A-4kt1A: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HJ3_C_MTXC613_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	VAL A 120 LEU A 184 LEU A 173 PHE A 149 LEU A 155	None	1.23A	3hj3C-4kt1A: undetectable	3hj3C-4kt1A: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K4V_D_ROCD201_3 (HIV-1 PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	3k4vD-4kt1A: undetectable	3k4vD-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MDT_A_VORA506_1 (CHOLESTEROL 24-HYDROXYLASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 9	LEU A 394 VAL A 420 ILE A 377 ALA A 408 THR A 384	None	1.28A	3mdtA-4kt1A: undetectable	3mdtA-4kt1A: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDT_D_ROCD100_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.88A	3ndtC-4kt1A: undetectable	3ndtC-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDT_D_ROCD100_2 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.84A	3ndtD-4kt1A: undetectable	3ndtD-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_A_ROCA101_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.86A	3nduA-4kt1A: undetectable	3nduA-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_A_ROCA101_2 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.85A	3nduB-4kt1A: undetectable	3nduB-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_D_ROCD100_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	3nduC-4kt1A: undetectable	3nduC-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_D_ROCD100_2 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.87A	3nduD-4kt1A: undetectable	3nduD-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXC_A_ROCA401_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.91A	3oxcA-4kt1A: undetectable	3oxcA-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXC_A_ROCA401_3 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.92A	3oxcB-4kt1A: undetectable	3oxcB-4kt1A: 10.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PWR_A_ROCA401_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.86A	3pwrA-4kt1A: undetectable	3pwrA-4kt1A: 10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKG_B_ROCB801_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.91A	3tkgA-4kt1A: undetectable	3tkgA-4kt1A: 11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKG_B_ROCB801_2 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.84A	3tkgB-4kt1A: undetectable	3tkgB-4kt1A: 11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKG_C_ROCC901_1 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.88A	3tkgC-4kt1A: undetectable	3tkgC-4kt1A: 11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DC3_A_ADNA401_1 (ADENOSINE KINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 321 ALA A 291 THR A 318 LEU A 298 ASP A 265	None	0.98A	4dc3A-4kt1A: undetectable	4dc3A-4kt1A: 21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_C_KANC301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 11	GLN A 113 ARG A 135 ASN A 187 ASP A 161 HIS A 140	None	1.45A	4gkhC-4kt1A: 0.0 4gkhD-4kt1A: 0.0	4gkhC-4kt1A: 19.57 4gkhD-4kt1A: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N16_A_CHDA301_0 (CARBONIC ANHYDRASE 2)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 8	ILE A 260 HIS A 278 PHE A 240 THR A 276	None	0.84A	4n16A-4kt1A: undetectable	4n16A-4kt1A: 18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKX_A_198A1002_2 (ANDROGEN RECEPTOR)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	4 / 6	LEU A 247 ASN A 271 LEU A 232 ILE A 277	None	0.91A	4okxA-4kt1A: undetectable	4okxA-4kt1A: 20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q5M_A_ROCA1101_2 (PROTEASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	GLY A 90 GLY A 45 PRO A 52 VAL A 51 ILE A 69	None	0.85A	4q5mA-4kt1A: undetectable	4q5mA-4kt1A: 17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZT_A_RTLA201_1 (RETINOL-BINDING PROTEIN 2)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	3 / 3	PHE A 312 THR A 384 LEU A 348	None	0.68A	4qztA-4kt1A: undetectable	4qztA-4kt1A: 14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.39A	4r88A-4kt1A: undetectable	4r88A-4kt1A: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.39A	4r88B-4kt1A: undetectable	4r88B-4kt1A: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.38A	4r88C-4kt1A: undetectable	4r88C-4kt1A: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.40A	4r88E-4kt1A: undetectable	4r88E-4kt1A: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.40A	4r88F-4kt1A: undetectable	4r88F-4kt1A: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4kt1	R-SPONDIN-1 (Homo sapiens)	5 / 12	ASP E 85 LEU E 64 GLU E 65 GLY E 82 ALA E 104	None	1.18A	4retA-4kt1E: undetectable	4retA-4kt1E: 6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4kt1	R-SPONDIN-1 (Homo sapiens)	5 / 12	ASP E 85 LEU E 64 GLU E 65 GLY E 82 ALA E 104	None	1.18A	4retC-4kt1E: undetectable	4retC-4kt1E: 6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 10	GLN A 342 LEU A 315 LEU A 338 LEU A 350 LEU A 345	None	1.22A	4yiaA-4kt1A: undetectable	4yiaA-4kt1A: 23.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YIA_B_IMNB401_1 (THYROXINE-BINDING GLOBULIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 10	SER A 215 LEU A 206 LEU A 184 SER A 191 LEU A 173	None	1.22A	4yiaA-4kt1A: undetectable	4yiaA-4kt1A: 23.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L8D_B_ACTB601_0 (NICKEL-BINDING PERIPLASMIC PROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	3 / 3	THR A 119 PRO A 145 ASP A 147	None	0.87A	5l8dB-4kt1A: undetectable	5l8dB-4kt1A: 25.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MWU_B_ACTB601_0 (NICKEL-BINDING PERIPLASMIC PROTEIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	3 / 3	THR A 119 PRO A 145 ASP A 147	None	0.87A	5mwuB-4kt1A: undetectable	5mwuB-4kt1A: 25.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TT3_A_EZLA303_1 (ALPHA-CARBONIC ANHYDRASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 R-SPONDIN-1 (Homo sapiens)	5 / 10	HIS A 157 VAL A 109 ALA E 104 PRO E 81 TRP A 159	None	1.13A	5tt3A-4kt1A: undetectable	5tt3A-4kt1A: 18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TT3_C_EZLC303_1 (ALPHA-CARBONIC ANHYDRASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 R-SPONDIN-1 (Homo sapiens)	5 / 10	HIS A 157 VAL A 109 ALA E 104 PRO E 81 TRP A 159	None	1.20A	5tt3C-4kt1A: undetectable	5tt3C-4kt1A: 18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 298 THR A 318 GLY A 317 VAL A 287 ILE A 303	None	1.16A	5tuiB-4kt1A: undetectable	5tuiB-4kt1A: 22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U6N_B_SALB504_1 (UDP-GLYCOSYLTRANSFER ASE 74F2)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 R-SPONDIN-1 (Homo sapiens)	4 / 6	SER A 133 HIS A 157 PHE E 110 GLN A 180	None	1.46A	5u6nB-4kt1A: undetectable	5u6nB-4kt1A: 22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA609_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	3 / 3	HIS A 320 HIS A 299 ARG A 275	None	0.82A	6b58A-4kt1A: undetectable	6b58A-4kt1A: 23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_B_AQ4B602_0 (CYTOCHROME P450 1A1)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	SER A 371 LEU A 425 ASN A 423 ASP A 395 PHE A 409	None	1.38A	6dwnB-4kt1A: undetectable	6dwnB-4kt1A: 9.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_C_AQ4C602_0 (CYTOCHROME P450 1A1)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 ASN A 423 ASP A 395 PHE A 409 LEU A 358	None	1.08A	6dwnC-4kt1A: undetectable	6dwnC-4kt1A: 9.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_D_AQ4D602_0 (CYTOCHROME P450 1A1)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	ILE A 244 GLY A 266 ALA A 291 ILE A 277 LEU A 295	None	1.09A	6dwnD-4kt1A: undetectable	6dwnD-4kt1A: 9.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_B_TA1B501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0B-4kt1A: undetectable	6ew0B-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_B_TA1B501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 208 LEU A 184 ALA A 243 LEU A 232 LEU A 250	None	1.12A	6ew0B-4kt1A: undetectable	6ew0B-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_D_TA1D501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0D-4kt1A: undetectable	6ew0D-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_D_TA1D501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 208 LEU A 184 ALA A 243 LEU A 232 LEU A 250	None	1.12A	6ew0D-4kt1A: undetectable	6ew0D-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_F_TA1F502_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0F-4kt1A: undetectable	6ew0F-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_G_TA1G501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0G-4kt1A: undetectable	6ew0G-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_H_TA1H501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0H-4kt1A: undetectable	6ew0H-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_H_TA1H501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 208 LEU A 184 ALA A 243 LEU A 232 LEU A 250	None	1.12A	6ew0H-4kt1A: undetectable	6ew0H-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_I_TA1I501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 93 ALA A 124 LEU A 117 GLN A 113 LEU A 134	None	1.13A	6ew0I-4kt1A: undetectable	6ew0I-4kt1A: 10.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_I_TA1I501_1 (TUBULIN BETA CHAIN)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 208 LEU A 184 ALA A 243 LEU A 232 LEU A 250	None	1.12A	6ew0I-4kt1A: undetectable	6ew0I-4kt1A: 10.46

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HSG_B_MK1B902_2","HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.88A","1hsgB-4kt1A:undetectable","1hsgB-4kt1A:10.96"],["1KIJ_B_NOVB444_2","DNA GYRASE SUBUNIT B","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",3,"ASP A 147;PHE A 149;VAL A 144","None","0.54A","1kijB-4kt1A:undetectable","1kijB-4kt1A:20.87"],["1OHR_A_1UNA201_1","ASPARTYLPROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.91A","1ohrA-4kt1A:undetectable","1ohrA-4kt1A:10.96"],["1P91_B_SAMB2401_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE A","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  62;GLY A  47;GLY A  45;LEU A 101;PRO A  73","None;NAG A 601 (-4.2A);None;None;None","0.97A","1p91B-4kt1A:undetectable","1p91B-4kt1A:19.96"],["1TBF_A_VIAA501_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 232;LEU A 216;VAL A 168;LEU A 182;PHE A 221","None","1.14A","1tbfA-4kt1A:undetectable","1tbfA-4kt1A:23.61"],["1TW4_A_CHDA131_0","FATTY ACID-BINDING PROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 367;ASN A 399;ILE A 377;LEU A 358;PHE A 385","None","1.34A","1tw4A-4kt1A:undetectable","1tw4A-4kt1A:13.79"],["1ZLQ_A_ACTA1502_0","NICKEL-BINDING PERIPLASMIC PROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"PRO A  32;GLY A  47;ASN A  67;GLY A  45","None;NAG A 601 (-4.2A);None;None","0.97A","1zlqA-4kt1A:undetectable","1zlqA-4kt1A:25.57"],["2AOI_C_FRDC305_1","POL POLYPROTEIN;PEPTIDE INHIBITOR","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","2aoiA-4kt1A:undetectable","2aoiA-4kt1A:10.69"],["2AOI_C_FRDC305_2","POL POLYPROTEIN;PEPTIDE INHIBITOR","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"LEU A  72;PRO A  52;VAL A  51;ILE A  69","None","0.94A","2aoiB-4kt1A:undetectable","2aoiB-4kt1A:10.69"],["2AVV_E_MK1E902_3","POL POLYPROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.89A","2avvE-4kt1A:undetectable","2avvE-4kt1A:10.89"],["2CDQ_A_SAMA1500_0","ASPARTOKINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"ILE A  64;SER A  44;ASP A  42;LEU A  62","None","0.99A","2cdqA-4kt1A:undetectable","2cdqA-4kt1A:22.36"],["2CEO_B_T44B1395_1","THYROXINE-BINDING GLOBULIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLN A 342;LEU A 315;LEU A 338;SER A 351;LEU A 350","None","1.33A","2ceoB-4kt1A:undetectable","2ceoB-4kt1A:21.33"],["2OIP_C_MTXC613_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"VAL A 120;LEU A 184;LEU A 173;PHE A 149;LEU A 155","None","1.24A","2oipC-4kt1A:undetectable","2oipC-4kt1A:22.43"],["2PYM_A_1UNA1001_1","PROTEASE RETROPEPSIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.80A","2pymA-4kt1A:undetectable","2pymA-4kt1A:12.62"],["2PYM_A_1UNA1001_2","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.83A","2pymB-4kt1A:undetectable","2pymB-4kt1A:12.62"],["2PYN_A_1UNA1001_1","PROTEASE RETROPEPSIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.82A","2pynA-4kt1A:undetectable","2pynA-4kt1A:12.30"],["2Q83_B_ADNB2_1","YTAA PROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"ILE A  69;PRO A 121;LEU A 101;ILE A  96","None","0.98A","2q83B-4kt1A:undetectable","2q83B-4kt1A:22.24"],["2QJU_A_DSMA801_1","TRANSPORTER","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 134;LEU A 110;ARG A 135;ALA A  89;ASP A 137","None","1.19A","2qjuA-4kt1A:undetectable","2qjuA-4kt1A:22.15"],["2VCT_A_ASDA1223_1","GLUTATHIONE S-TRANSFERASE A2","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"ILE A 260;LEU A 232;LEU A 230;PHE A 268","None","0.89A","2vctA-4kt1A:undetectable","2vctA-4kt1A:19.52"],["2Z54_A_AB1A200_2","HIV-1 PROTEASE;HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.91A","2z54B-4kt1A:undetectable","2z54B-4kt1A:10.58"],["3CYX_A_ROCA201_1","HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.80A","3cyxA-4kt1A:undetectable","3cyxA-4kt1A:10.69"],["3D1X_A_ROCA201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.91A","3d1xB-4kt1A:undetectable","3d1xB-4kt1A:13.10"],["3D1Y_A_ROCA201_1","HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","3d1yA-4kt1A:undetectable","3d1yA-4kt1A:13.33"],["3EM4_A_DR7A100_1","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","3em4A-4kt1A:undetectable","3em4A-4kt1A:12.50"],["3HJ3_C_MTXC613_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"VAL A 120;LEU A 184;LEU A 173;PHE A 149;LEU A 155","None","1.23A","3hj3C-4kt1A:undetectable","3hj3C-4kt1A:22.60"],["3K4V_D_ROCD201_3","HIV-1 PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","3k4vD-4kt1A:undetectable","3k4vD-4kt1A:10.69"],["3MDT_A_VORA506_1","CHOLESTEROL 24-HYDROXYLASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 394;VAL A 420;ILE A 377;ALA A 408;THR A 384","None","1.28A","3mdtA-4kt1A:undetectable","3mdtA-4kt1A:21.88"],["3NDT_D_ROCD100_1","PROTEASE;PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.88A","3ndtC-4kt1A:undetectable","3ndtC-4kt1A:10.69"],["3NDT_D_ROCD100_2","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.84A","3ndtD-4kt1A:undetectable","3ndtD-4kt1A:10.69"],["3NDU_A_ROCA101_1","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.86A","3nduA-4kt1A:undetectable","3nduA-4kt1A:10.69"],["3NDU_A_ROCA101_2","PROTEASE;PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.85A","3nduB-4kt1A:undetectable","3nduB-4kt1A:10.69"],["3NDU_D_ROCD100_1","PROTEASE;PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","3nduC-4kt1A:undetectable","3nduC-4kt1A:10.69"],["3NDU_D_ROCD100_2","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.87A","3nduD-4kt1A:undetectable","3nduD-4kt1A:10.69"],["3OXC_A_ROCA401_1","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.91A","3oxcA-4kt1A:undetectable","3oxcA-4kt1A:10.69"],["3OXC_A_ROCA401_3","PROTEASE;PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.92A","3oxcB-4kt1A:undetectable","3oxcB-4kt1A:10.69"],["3PWR_A_ROCA401_1","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.86A","3pwrA-4kt1A:undetectable","3pwrA-4kt1A:10.50"],["3TKG_B_ROCB801_1","PROTEASE;PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.91A","3tkgA-4kt1A:undetectable","3tkgA-4kt1A:11.67"],["3TKG_B_ROCB801_2","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.84A","3tkgB-4kt1A:undetectable","3tkgB-4kt1A:11.67"],["3TKG_C_ROCC901_1","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.88A","3tkgC-4kt1A:undetectable","3tkgC-4kt1A:11.67"],["4DC3_A_ADNA401_1","ADENOSINE KINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 321;ALA A 291;THR A 318;LEU A 298;ASP A 265","None","0.98A","4dc3A-4kt1A:undetectable","4dc3A-4kt1A:21.90"],["4GKH_C_KANC301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB;AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLN A 113;ARG A 135;ASN A 187;ASP A 161;HIS A 140","None","1.45A","4gkhC-4kt1A:0.0;4gkhD-4kt1A:0.0","4gkhC-4kt1A:19.57;4gkhD-4kt1A:19.57"],["4N16_A_CHDA301_0","CARBONIC ANHYDRASE 2","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"ILE A 260;HIS A 278;PHE A 240;THR A 276","None","0.84A","4n16A-4kt1A:undetectable","4n16A-4kt1A:18.42"],["4OKX_A_198A1002_2","ANDROGEN RECEPTOR","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",4,"LEU A 247;ASN A 271;LEU A 232;ILE A 277","None","0.91A","4okxA-4kt1A:undetectable","4okxA-4kt1A:20.12"],["4Q5M_A_ROCA1101_2","PROTEASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLY A  90;GLY A  45;PRO A  52;VAL A  51;ILE A  69","None","0.85A","4q5mA-4kt1A:undetectable","4q5mA-4kt1A:17.39"],["4QZT_A_RTLA201_1","RETINOL-BINDING PROTEIN 2","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",3,"PHE A 312;THR A 384;LEU A 348","None","0.68A","4qztA-4kt1A:undetectable","4qztA-4kt1A:14.42"],["4R88_A_1LDA501_0","CYTOSINE DEAMINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;PHE A 409;ILE A 380;GLU A 449;LEU A 447","None","1.39A","4r88A-4kt1A:undetectable","4r88A-4kt1A:23.87"],["4R88_B_1LDB501_0","CYTOSINE DEAMINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;PHE A 409;ILE A 380;GLU A 449;LEU A 447","None","1.39A","4r88B-4kt1A:undetectable","4r88B-4kt1A:23.87"],["4R88_C_1LDC501_0","CYTOSINE DEAMINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;PHE A 409;ILE A 380;GLU A 449;LEU A 447","None","1.38A","4r88C-4kt1A:undetectable","4r88C-4kt1A:23.87"],["4R88_E_1LDE501_0","CYTOSINE DEAMINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;PHE A 409;ILE A 380;GLU A 449;LEU A 447","None","1.40A","4r88E-4kt1A:undetectable","4r88E-4kt1A:23.87"],["4R88_F_1LDF502_0","CYTOSINE DEAMINASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;PHE A 409;ILE A 380;GLU A 449;LEU A 447","None","1.40A","4r88F-4kt1A:undetectable","4r88F-4kt1A:23.87"],["4RET_A_DGXA1107_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","4kt1","R-SPONDIN-1","Homo sapiens",5,"ASP E  85;LEU E  64;GLU E  65;GLY E  82;ALA E 104","None","1.18A","4retA-4kt1E:undetectable","4retA-4kt1E:6.35"],["4RET_C_DGXC2005_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","4kt1","R-SPONDIN-1","Homo sapiens",5,"ASP E  85;LEU E  64;GLU E  65;GLY E  82;ALA E 104","None","1.18A","4retC-4kt1E:undetectable","4retC-4kt1E:6.35"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"GLN A 342;LEU A 315;LEU A 338;LEU A 350;LEU A 345","None","1.22A","4yiaA-4kt1A:undetectable","4yiaA-4kt1A:23.25"],["4YIA_B_IMNB401_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"SER A 215;LEU A 206;LEU A 184;SER A 191;LEU A 173","None","1.22A","4yiaA-4kt1A:undetectable","4yiaA-4kt1A:23.25"],["5L8D_B_ACTB601_0","NICKEL-BINDING PERIPLASMIC PROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",3,"THR A 119;PRO A 145;ASP A 147","None","0.87A","5l8dB-4kt1A:undetectable","5l8dB-4kt1A:25.57"],["5MWU_B_ACTB601_0","NICKEL-BINDING PERIPLASMIC PROTEIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",3,"THR A 119;PRO A 145;ASP A 147","None","0.87A","5mwuB-4kt1A:undetectable","5mwuB-4kt1A:25.57"],["5TT3_A_EZLA303_1","ALPHA-CARBONIC ANHYDRASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4;R-SPONDIN-1","Homo sapiens",5,"HIS A 157;VAL A 109;ALA E 104;PRO E  81;TRP A 159","None","1.13A","5tt3A-4kt1A:undetectable","5tt3A-4kt1A:18.32"],["5TT3_C_EZLC303_1","ALPHA-CARBONIC ANHYDRASE","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4;R-SPONDIN-1","Homo sapiens",5,"HIS A 157;VAL A 109;ALA E 104;PRO E  81;TRP A 159","None","1.20A","5tt3C-4kt1A:undetectable","5tt3C-4kt1A:18.32"],["5TUI_B_CTCB405_0","TETRACYCLINE DESTRUCTASE TET(50)","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 298;THR A 318;GLY A 317;VAL A 287;ILE A 303","None","1.16A","5tuiB-4kt1A:undetectable","5tuiB-4kt1A:22.72"],["5U6N_B_SALB504_1","UDP-GLYCOSYLTRANSFERASE 74F2","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4;R-SPONDIN-1","Homo sapiens",4,"SER A 133;HIS A 157;PHE E 110;GLN A 180","None","1.46A","5u6nB-4kt1A:undetectable","5u6nB-4kt1A:22.74"],["6B58_A_ACTA609_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",3,"HIS A 320;HIS A 299;ARG A 275","None","0.82A","6b58A-4kt1A:undetectable","6b58A-4kt1A:23.00"],["6DWN_B_AQ4B602_0","CYTOCHROME P450 1A1","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"SER A 371;LEU A 425;ASN A 423;ASP A 395;PHE A 409","None","1.38A","6dwnB-4kt1A:undetectable","6dwnB-4kt1A:9.62"],["6DWN_C_AQ4C602_0","CYTOCHROME P450 1A1","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 425;ASN A 423;ASP A 395;PHE A 409;LEU A 358","None","1.08A","6dwnC-4kt1A:undetectable","6dwnC-4kt1A:9.62"],["6DWN_D_AQ4D602_0","CYTOCHROME P450 1A1","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"ILE A 244;GLY A 266;ALA A 291;ILE A 277;LEU A 295","None","1.09A","6dwnD-4kt1A:undetectable","6dwnD-4kt1A:9.62"],["6EW0_B_TA1B501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0B-4kt1A:undetectable","6ew0B-4kt1A:10.46"],["6EW0_B_TA1B501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 208;LEU A 184;ALA A 243;LEU A 232;LEU A 250","None","1.12A","6ew0B-4kt1A:undetectable","6ew0B-4kt1A:10.46"],["6EW0_D_TA1D501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0D-4kt1A:undetectable","6ew0D-4kt1A:10.46"],["6EW0_D_TA1D501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 208;LEU A 184;ALA A 243;LEU A 232;LEU A 250","None","1.12A","6ew0D-4kt1A:undetectable","6ew0D-4kt1A:10.46"],["6EW0_F_TA1F502_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0F-4kt1A:undetectable","6ew0F-4kt1A:10.46"],["6EW0_G_TA1G501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0G-4kt1A:undetectable","6ew0G-4kt1A:10.46"],["6EW0_H_TA1H501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0H-4kt1A:undetectable","6ew0H-4kt1A:10.46"],["6EW0_H_TA1H501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 208;LEU A 184;ALA A 243;LEU A 232;LEU A 250","None","1.12A","6ew0H-4kt1A:undetectable","6ew0H-4kt1A:10.46"],["6EW0_I_TA1I501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A  93;ALA A 124;LEU A 117;GLN A 113;LEU A 134","None","1.13A","6ew0I-4kt1A:undetectable","6ew0I-4kt1A:10.46"],["6EW0_I_TA1I501_1","TUBULIN BETA CHAIN","4kt1","LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4","Homo sapiens",5,"LEU A 208;LEU A 184;ALA A 243;LEU A 232;LEU A 250","None","1.12A","6ew0I-4kt1A:undetectable","6ew0I-4kt1A:10.46"]]